Clinical Trials Directory

Trials / Unknown

UnknownNCT05003154

Digitalized Management Exploration for Gestational Diabetes Mellitus in China

Comparison of Conventional Mode and Combined Digitalized Mode of Management for Gestational Diabetes Mellitus in China

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
46 (estimated)
Sponsor
Women's Hospital School Of Medicine Zhejiang University · Academic / Other
Sex
Female
Age
18 Years – 45 Years
Healthy volunteers
Not accepted

Summary

Gestational diabetes mellitus (GDM) can lead to adverse perinatal and long-term outcomes, and it is so important to manage this disease in pregnancy. Digitalized managements have been proved economical and effective in some chronic diseases like type II diabetes mellitus. The purpose of the current study was to develop and evaluate a digitalized mode for GDM management using mobile healthcare and some wearable devices. Subjects were randomly divided into a conventional management group and combined digitalized management group after diagnosed with GDM during 24-28 weeks of gestation. The conventional mangement group received conventional GDM management and could freely use the mobile healthcare application. The mobile management group received digitalized healthcare services from artificial intelligence under the supervision of obstetricians, in addition to conventional management. The effectiveness of digitalized management were evaluated mainly through the result values of the labotatory tests related to blood glucose controlling and perinatal outcomes.

Conditions

Interventions

TypeNameDescription
OTHERDigitalized managementIn addition to conventional management, Patients also receive digitalized management, which provides personalized guidance in diet, excercise, prenatal visit, blood glucose monitoring,etc., from artificail intelliegence (AI) supevised by obstetricians, through a smartphone application and some werable devices (like sports bracelet). The pivotal AI are based on clinical experience from obstetricians, therapeutic principle from official Guidelines and abundant data in previous work, and it will works under strict supervision.

Timeline

Start date
2021-09-01
Primary completion
2024-01-01
Completion
2024-08-01
First posted
2021-08-12
Last updated
2021-08-12

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05003154. Inclusion in this directory is not an endorsement.